SABCS 2020

San Antonio Breast Cancer Symposium

08–11 December 2020 | Virtual Meeting

The San Antonio Breast Cancer Symposium (SABCS) Annual meeting will be held virtually this year due to the ongoing COVID-19 pandemic and will highlight recent advances in the treatment and management of breast cancer.

View all videos

Exciting trial updates from the upcoming SABCS 2020 meeting

Cynthia X. Ma • 3 Dec 2020

An evaluation of the impact of DCIS diagnosis on the patients’ wellbeing

Eileen Rakovitch • 1 Dec 2020

Reducing disparities in breast cancer care

Oluwadamilola Fayanju • 1 Dec 2020

Challenges in applying AI in healthcare

Constance Lehman • 4 Dec 2020

What to expect in breast cancer in 2021

Cynthia X. Ma • 3 Dec 2020

Future of genomics in breast cancer care

Andrew McKenzie et al. • 4 Dec 2020

ASCENT: sacituzumab govitecan shows promise in mTNBC patients

Sara Hurvitz • 30 Nov 2020

ASCENT: sacituzumab govitecan biomarker analysis

Sara Tolaney • 11 Dec 2020

SABCS 2020: monarchE, PENELOPE-B, TAILORx & ASCENT

Matteo Lambertini • 9 Dec 2020

HER2CLIMB-02: tucatinib + TDM-1 in advanced breast cancer

Sara Hurvitz • 2 Dec 2020

HER2CLIMB: outcomes by hormone receptor status

Erika Hamilton • 15 Dec 2020

CONTESSA: tesataxel in HR+ breast cancer

Sara Tolaney • 11 Dec 2020

Biology informing treatment decisions in breast cancer

Laura J. van 't Veer • 3 Dec 2020

The role of gut microbiome in breast cancer risk

Timothy Robinson • 1 Dec 2020

SWOG S9313: classification of TNBC by DNA damage response + homologous recombination deficiency

Shane Stecklein • 8 Dec 2020

Updated outcomes from MINDACT

Laura J. van 't Veer • 4 Dec 2020

Future advances in DCIS: de-escalation of hormonal therapy

Ivana Sestak • 10 Dec 2020

Future of breast cancer care: HER2 therapies in earlier settings & de-escalation

Sibylle Loibl • 10 Dec 2020

RxPONDER: sparing chemotherapy in node-positive early-stage breast cancer

Sara Tolaney • 11 Dec 2020

Treatment optimization trials in breast cancer

Sara Tolaney • 11 Dec 2020